Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

Biochemical and Biophysical Research Communications

Volumn 274, Issue 1, 2000, Pages 61-67

  Mizutani, Kenichi ^a   Ikeda, Katsumi ^a   Yamori, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycosylation end products; Phytestrogen; Stroke prone spontaneously hypertensive rats; Vascular smooth muscle cell

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIMITOTIC AGENT; COLLAGEN; DNA; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RESVERATROL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GLYCATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 0033916480     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3097     Document Type: Article

References (51)

1. Folkow B. Physiological aspects of primary hypertension. Physiol. Rev. 62:1982;347-504.
2. Mulvany M. J., Baumbach G. L., Aalkjaer C., Heagerty A. M., Korsgaard N., Schiffrin E. L., Heistad D. D. Vascular remodeling. Hypertension. 28:1996;505-506.
3. Mulvany M. L. Remodeling of resistance vessel structure in essential hypertension. Curr. Opin. Nephrol. Hypertens. 2:1993;77-81.
4. Hadrava V., Tremblay J., Hamet P. Intrinsic factors involved in vascular smooth muscle cell proliferation in hypertension. Clin. Invest. Med. 14:1991;535-544.
5. Yamori Y., Igawa T., Kanbe T., Nara Y., Tagami M. Enhanced growth rate of smooth muscle cells from spontaneously hypertensive rats. Heart Vessels. 4:1988;97-99.
6. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101:1984;527-537.
7. Njoroge F. G., Monnier V. M. The chemistry of the maillard reaction under physiological conditions: A review. Prog. Clin. Biol. Res. 304:1989;85-107.
8. Ledl F., Beck J., Sengl M., Osiander H., Estendorfer S., Severin T., Huber B. Chemical pathways of the maillard reaction. Prog. Clin. Biol. Res. 304:1989;23-42.
9. Bruel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 127:1996;155-165.
10. Monnier V. M., Sell D. R., Nagaraj R. H., Miyata S., Grandhee S., Odetti P., Ibrahim S. A. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes. 41:1992;36-41.
11. Sell D. R., Carlson E. C., Monnier V. M. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane. Diabetologia. 36:1993;936-941.
12. Satoh H., Togo M., Hara M., Miyata T., Han K., Maekawa H., Ohno M., Hashimoto Y., Kurokawa K., Watanabe T. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 239:1997;111-115.
13. Taniguchi N., Kaneto H., Asahi M., Takahashi M., Wenyi C., Higashiyama S., Fujii J., Suzuki K., Kayanoki Y. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 45:1996;S81-83.
14. Meng J., Sakata N., Takebayashi S., Asano T., Futata T., Nagai R., Ikeda K., Horiuchi S., Myint T., Taniguchi N. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis. 136:1998;355-365.
15. Mizutani K., Ikeda K., Ito T., Tamaki K., Nara Y., Yamori Y. Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advanced glycation end-products in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J. Hypertens. 2000.
16. Mizutani K., Ikeda K., Kawai Y., Yamori Y. Biomechanical properties and chemical composition of the aorta in genetic hypertensive rats. J. Hypertens. 17:1999;481-487.
17. Cathapermal S., Lavigne M. C., Leong-Son M., Alibadi T., Ramwell P. W. Steroisomer-specific inhibition of superoxide anion-induced rat aortic smooth muscle cell proliferation by 17β-estradiol is estrogen receptor dependent. J. Biol. Chem. 267:1992;12404-12407.
18. Wagner J. D., St Clair R. W., Schwenke D. C., Shively C. A., Adams M. R., Clarkson T. B. Regional differences in arterial low-density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys: Effects of estrogen and progesterone therapy. Arterioscler. Thromb. 12:1992;717-726.
19. Mooradian A. D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45:1993;509-511.
20. Walsh B. A., Busch B. L., Mullick A. E., Reiser K. M., Rutledge J. C. 17β-Estradiol reduces glycoxidative damage in the artery wall. Arterioscler. Thromb. Vasc. Biol. 19:1999;840-846.
21. Gehm B. D., Mcandrews J. M., Chien P. Y., Jameson J. L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA. 94:1997;14138-14143.
22. Jang M., Cai L., Udeani G. O., Slowing K. V., Thomas C. F., Beecher C. W., Fong H. H., Farnsworth N. R., Kinghorn A. D., Mehta R. G., Moon R. C., Pezzuto J. M. Cancer chemopreventative activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
23. Mizutani K., Ikeda K., Kawai Y., Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 253:1998;859-863.
24. Frankel E. N., Waterhouse A. L., Kinsella J. E. Inhibition of human LDL oxidation by resveratrol. Lancet. 341:1993;1103-1104.
25. Kimura Y., Okuda H., Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta. 834:1985;275-278.
26. Mizutani K., Ikeda K., Kawai Y., Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 46:2000;78-83.
27. Yamori Y. Pathogenesis of spontaneously hypertension as a model for essential hypertension. Jpn. Circ. 41:1977;259-266.
28. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
29. Sanburn N., Cornetta K. Rapid titer determination using quantitative real-time PCR. Gene Ther. 6:1999;1340-1345.
30. Tricarico C., Salvadori B., Villari D., Nicita G., Melina D. A., Pinzani P., Ziche M., Pazzagli M. Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. Int. J. Biol. Markers. 14:1999;247-250.
31. Wingo T. S., Ringel D. M., Anderson S. J., Patel D. A., Lukes D. Y., Djuh Y. Y., Solomon B., Nicholson D., Balducci-Silano L. P., Levine A. M., Francis L. G., Tuttle M. R. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin. Chem. 45:1999;785-789.
32. Brett J., Schmidt A. M., Yan S. D., Zou Y. S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., Shaw A. Survey of the distribution of a newly characterization receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1993;1699-1712.
33. Takata K., Horiuchi S., Araki N., Shiga M., Saitoh M., Morino Y. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J. Biol. Chem. 263:1988;14819-14825.
34. Higashi T., Sano H., Saishoji T., Ikeda K., Jinnouchi Y., Kanzaki T., Morisaki N., Rauvala H., Shichiri M., Horiuchi S. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes. 46:1997;463-472.
35. Grotendorst G. R., Chang T., Seppa H. E. J., Kleinman H. K., Martin G. R. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell Physiol. 113:1982;261-266.
36. Jawien A., Bowen-Pope D. F., Lindner V., Schwartz S. M., Clowes A. W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:1992;507-511.
37. Ignotz R. A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 232:1986;1629-1632.
38. Chen J., Hoshi H., McKeehan W. L. Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA. 84:1987;5287-5291.
39. Makita Z., Vlassara H., Rayfield E. Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science. 258:1992;651-653.
40. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G. E., Striker L. J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 89:1992;2873-2877.
41. Miyazawa K., Kikuchi S., Fukuyama J., Hamano S., Ujiie A. Inhibition of PDGF- and TGF-β1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis. 118:1995;213-221.
42. Anderson B., Mattsson L. A., Hahn L., Marin P., Lapidus L., Holm G., Bengtsson B. A., Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82:1997;638-643.
43. Anthony M. S., Clarkson T. B., Hughes C. L., Morgan T. M., Burke G. L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkey. J. Nutr. 126:1996;43-50.
44. Wagner J. D., Cefalu W. T., Anthony M. S., Litwak K. N., Zhang L., Clarkson T. B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 46:1997;698-705.
45. Dodge J. A., Glasebrook A. L., Magee D. E., Philips D. L., Sato M., Short L. L., Bryant H. U. Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat. J. Steroid Biochem. Mol. Biol. 59:1996;155-161.
46. Goldberg D. M., Karumanchiri A., Yan J., Diamandis E. P. Assay of resveratrol glucosides and isomers in wine by direct-injection high-performance liquid chromatography. J. Chromatogr. 708:1995;89-98.
47. Mizutani K., Ikeda K., Kawai Y., Yamori Y. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J. Nutr. Sci. Vitaminol. 45:1999;95-106.
48. Cathapermal S., Lavigne M. C., Leong-Son M., Alibadi T., Ramwell P. W. Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17β-estradiol is estrogen receptor dependent. J. Cardiovasc. Pharmacol. 31:1998;499-505.
49. Jackson C. L., Schwartz S. M. Pharmacology of smooth muscle cell replication. Hypertension. 20:1992;713-736.
50. Wang T. T. Y., Sathyamoorthy N., Phang J. M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 17:1996;271-275.
51. Rosselli M., Keller P. J., Kern F., Hahn A. W. A., Dubey R. K. Estradiol inhibits mitogen-induced proliferation and migration of human aortic smooth muscle cells: Implications for cardiovascular disease in women. Circulation. 90:1994;I-87.